标题
Next-generation antimicrobials: from chemical biology to first-in-class drugs
作者
关键词
Drug discovery, Antimicrobials, First-in-class drugs, Screening, Lead optimization, Chemical biology
出版物
ARCHIVES OF PHARMACAL RESEARCH
Volume 38, Issue 9, Pages 1702-1717
出版商
Springer Nature
发表日期
2015-08-10
DOI
10.1007/s12272-015-0645-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Stress and Host Immunity Amplify Mycobacterium tuberculosis Phenotypic Heterogeneity and Induce Nongrowing Metabolically Active Forms
- (2015) Giulia Manina et al. Cell Host & Microbe
- Exogenous Alanine and/or Glucose plus Kanamycin Kills Antibiotic-Resistant Bacteria
- (2015) Bo Peng et al. Cell Metabolism
- Antimalarial compounds in Phase II clinical development
- (2015) Jana Held et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Small-Molecule Inhibitors of Gram-Negative Lipoprotein Trafficking Discovered by Phenotypic Screening
- (2015) Sarah M. McLeod et al. JOURNAL OF BACTERIOLOGY
- Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
- (2015) Rodney Dawson et al. LANCET
- Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker
- (2015) Kyaw M Tun et al. LANCET INFECTIOUS DISEASES
- A novel multiple-stage antimalarial agent that inhibits protein synthesis
- (2015) Beatriz Baragaña et al. NATURE
- A new antibiotic kills pathogens without detectable resistance
- (2015) Losee L. Ling et al. NATURE
- Timing is everything for compassionate use of delamanid
- (2015) Clifton E Barry NATURE MEDICINE
- Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis
- (2015) Michael B. Harbut et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Direct inhibitors of InhA are active against Mycobacterium tuberculosis
- (2015) U. H. Manjunatha et al. Science Translational Medicine
- Lansoprazole is an antituberculous prodrug targeting cytochrome bc1
- (2015) Jan Rybniker et al. Nature Communications
- Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate
- (2015) Shahul Hameed P. et al. Nature Communications
- Novel Inhibitors of Cholesterol Degradation in Mycobacterium tuberculosis Reveal How the Bacterium’s Metabolism Is Constrained by the Intracellular Environment
- (2015) Brian C. VanderVen et al. PLoS Pathogens
- Contribution of the Nitroimidazoles PA-824 and TBA-354 to the Activity of Novel Regimens in Murine Models of Tuberculosis
- (2014) Rokeya Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
- (2014) F. Joel Leong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anticytolytic Screen Identifies Inhibitors of Mycobacterial Virulence Protein Secretion
- (2014) Jan Rybniker et al. Cell Host & Microbe
- Targeting Bacterial Central Metabolism for Drug Development
- (2014) Paul Murima et al. CHEMISTRY & BIOLOGY
- Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent
- (2014) Sunhee Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- N-Aryl-2-aminobenzimidazoles: Novel, Efficacious, Antimalarial Lead Compounds
- (2014) Sreekanth Ramachandran et al. JOURNAL OF MEDICINAL CHEMISTRY
- Spiroindolone KAE609 for Falciparum and Vivax Malaria
- (2014) Nicholas J. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Establishment and Validation of Whole-Cell Based Fluorescence Assays to Identify Anti-Mycobacterial Compounds Using the Acanthamoeba castellanii - Mycobacterium marinum Host-Pathogen System
- (2014) Sébastien Kicka et al. PLoS One
- An Image-Based Algorithm for Precise and Accurate High Throughput Assessment of Drug Activity against the Human Parasite Trypanosoma cruzi
- (2014) Seunghyun Moon et al. PLoS One
- (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance ofPlasmodium
- (2014) María Belén Jiménez-Díaz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lead Optimization of Imidazopyrazines: A New Class of Antimalarial with Activity on Plasmodium Liver Stages
- (2014) Bin Zou et al. ACS Medicinal Chemistry Letters
- Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum
- (2014) Akhil B. Vaidya et al. Nature Communications
- Identification of Host-Targeted Small Molecules That Restrict Intracellular Mycobacterium tuberculosis Growth
- (2014) Sarah A. Stanley et al. PLoS Pathogens
- Development of anEx VivoLymph Node Explant Model for Identification of Novel Molecules Active against Leishmania major
- (2013) Alex G. Peniche et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Microscale Human Liver Platform that Supports the Hepatic Stages of Plasmodium falciparum and vivax
- (2013) Sandra March et al. Cell Host & Microbe
- Integration of Chemical and RNAi Multiparametric Profiles Identifies Triggers of Intracellular Mycobacterial Killing
- (2013) Varadharajan Sundaramurthy et al. Cell Host & Microbe
- Na+ Regulation in the Malaria Parasite Plasmodium falciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone Antimalarials
- (2013) Natalie J. Spillman et al. Cell Host & Microbe
- Collapsing the Proton Motive Force to Identify Synergistic Combinations against Staphylococcus aureus
- (2013) Maya A. Farha et al. CHEMISTRY & BIOLOGY
- Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
- (2013) Lluís Ballell et al. ChemMedChem
- 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America
- (2013) H. W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
- (2013) D C Swinney CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pyridomycin bridges the NADH- and substrate-binding pockets of the enoyl reductase InhA
- (2013) Ruben C Hartkoorn et al. Nature Chemical Biology
- Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation
- (2013) Soumaya Zlitni et al. Nature Chemical Biology
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish
- (2013) Kevin Takaki et al. Nature Protocols
- Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
- (2013) Katherine A. Abrahams et al. PLoS One
- Transgenic Fluorescent Plasmodium cynomolgi Liver Stages Enable Live Imaging and Purification of Malaria Hypnozoite-Forms
- (2013) Annemarie Voorberg-van der Wel et al. PLoS One
- Approval of Novel TB Drug Celebrated--With Restraint
- (2013) J. Cohen SCIENCE
- Dynamic Persistence of Antibiotic-Stressed Mycobacteria
- (2013) Y. Wakamoto et al. SCIENCE
- Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
- (2013) S. P. S. Rao et al. Science Translational Medicine
- Towards a new tuberculosis drug: pyridomycin - nature's isoniazid
- (2012) Ruben C. Hartkoorn et al. EMBO Molecular Medicine
- 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
- (2012) Andreas H Diacon et al. LANCET
- Liver-stage malaria parasites vulnerable to diverse chemical scaffolds
- (2012) E. R. Derbyshire et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transgenic parasites accelerate drug discovery
- (2012) Ana Rodriguez et al. TRENDS IN PARASITOLOGY
- An In Vivo Platform for Rapid High-Throughput Antitubercular Drug Discovery
- (2012) Kevin Takaki et al. Cell Reports
- Identification of Compounds with Anti-Proliferative Activity against Trypanosoma brucei brucei Strain 427 by a Whole Cell Viability Based HTS Campaign
- (2012) Melissa L. Sykes et al. PLoS Neglected Tropical Diseases
- An Image-Based High-Content Screening Assay for Compounds Targeting Intracellular Leishmania donovani Amastigotes in Human Macrophages
- (2012) Jair L. Siqueira-Neto et al. PLoS Neglected Tropical Diseases
- Linking the Transcriptional Profiles and the Physiological States of Mycobacterium tuberculosis during an Extended Intracellular Infection
- (2012) Kyle H. Rohde et al. PLoS Pathogens
- Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?
- (2012) Lucio H. Freitas-Junior et al. International Journal for Parasitology-Drugs and Drug Resistance
- Cyclopropyl Carboxamides, a Chemically Novel Class of Antimalarial Agents Identified in a Phenotypic Screen
- (2011) Laura M. Sanz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Selective Killing of Bacterial Persisters by a Single Chemical Compound without Affecting Normal Antibiotic-Sensitive Cells
- (2011) Jun-Seob Kim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Report of the 2nd Chagas Drug Discovery Consortium meeting, held on 3 November 2010; Atlanta GA, USA
- (2011) Juan M Bustamante et al. Expert Opinion on Drug Discovery
- How antibacterials really work: impact on drug discovery
- (2011) Thomas Dick et al. Future Microbiology
- Metabolite-enabled eradication of bacterial persisters by aminoglycosides
- (2011) Kyle R. Allison et al. NATURE
- Targeting cancer metabolism: a therapeutic window opens
- (2011) Matthew G. Vander Heiden NATURE REVIEWS DRUG DISCOVERY
- Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
- (2011) S. Meister et al. SCIENCE
- Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity
- (2011) Garrett C. Moraski et al. ACS Medicinal Chemistry Letters
- Metabolic Regulation of Mycobacterial Growth and Antibiotic Sensitivity
- (2011) Seung-Hun Baek et al. PLOS BIOLOGY
- Identification of Small Molecule Lead Compounds for Visceral Leishmaniasis Using a Novel Ex Vivo Splenic Explant Model System
- (2011) Yaneth Osorio et al. PLoS Neglected Tropical Diseases
- The SYBR Green I Malaria Drug Sensitivity Assay: Performance in Low Parasitemia Samples
- (2010) Matthias G. Vossen et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Image-Based High-Throughput Drug Screening Targeting the Intracellular Stage of Trypanosoma cruzi, the Agent of Chagas' Disease
- (2010) J. C. Engel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Use of Ichip for High-Throughput In Situ Cultivation of "Uncultivable" Microbial Species
- (2010) D. Nichols et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosis
- (2010) Dhiraj Kumar et al. CELL
- Siderophores from Neighboring Organisms Promote the Growth of Uncultured Bacteria
- (2010) Anthony D'Onofrio et al. CHEMISTRY & BIOLOGY
- High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery
- (2010) Thierry Christophe et al. Future Medicinal Chemistry
- Progress and Challenges in Implementing the Research on ESKAPE Pathogens
- (2010) Louis B. Rice INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of Malaria
- (2010) Bryan K. S. Yeung et al. JOURNAL OF MEDICINAL CHEMISTRY
- Thousands of chemical starting points for antimalarial lead identification
- (2010) Francisco-Javier Gamo et al. NATURE
- Chemical genetics of Plasmodium falciparum
- (2010) W. Armand Guiguemde et al. NATURE
- Establishment of an In Vitro Assay for Assessing the Effects of Drugs on the Liver Stages of Plasmodium vivax Malaria
- (2010) Rana Chattopadhyay et al. PLoS One
- Spiroindolones, a Potent Compound Class for the Treatment of Malaria
- (2010) M. Rottmann et al. SCIENCE
- Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
- (2010) Timothy N.C. Wells et al. TRENDS IN PARASITOLOGY
- A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
- (2010) Kevin Pethe et al. Nature Communications
- In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
- (2010) Adriana M. C. Canavaci et al. PLoS Neglected Tropical Diseases
- Development of an Alamar Blue™ Viability Assay in 384-Well Format for High Throughput Whole Cell Screening of Trypanosoma brucei brucei Bloodstream Form Strain 427
- (2009) Melissa L. Sykes et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Current Treatment and Drug Discovery Against Leishmania spp. and Plasmodium spp.: A Review
- (2009) Angela Cruz et al. CURRENT DRUG TARGETS
- Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens
- (2009) Sophie Brinster et al. NATURE
- Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge
- (2009) Cesar A. Arias et al. NEW ENGLAND JOURNAL OF MEDICINE
- Artemisinin Resistance inPlasmodium falciparumMalaria
- (2009) Arjen M. Dondorp et al. NEW ENGLAND JOURNAL OF MEDICINE
- A luciferase based viability assay for ATP detection in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427
- (2009) Melissa L Sykes et al. Parasites & Vectors
- A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore
- (2009) J. Richard Miller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- Comprehensive Characterization of Genes Required for Protein Folding in the Endoplasmic Reticulum
- (2009) M. C. Jonikas et al. SCIENCE
- Antibiotics for Emerging Pathogens
- (2009) M. A. Fischbach et al. SCIENCE
- Identification of Three Classes of Heteroaromatic Compounds with Activity against Intracellular Trypanosoma cruzi by Chemical Library Screening
- (2009) Esther Bettiol et al. PLoS Neglected Tropical Diseases
- High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors
- (2009) Thierry Christophe et al. PLoS Pathogens
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Plasmodium falciparum: Development and validation of a measure of intraerythrocytic growth using SYBR Green I in a flow cytometer
- (2008) Shinji Izumiyama et al. EXPERIMENTAL PARASITOLOGY
- Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
- (2008) Louis B. Rice JOURNAL OF INFECTIOUS DISEASES
- Revisiting the host as a growth medium
- (2008) Stacie A. Brown et al. NATURE REVIEWS MICROBIOLOGY
- In silicoactivity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
- (2008) David Plouffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis
- (2008) S. P. S. Rao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now